GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Huaheng Biotechnology Co Ltd (SHSE:688639) » Definitions » Change In Receivables

Anhui Huaheng Biotechnology Co (SHSE:688639) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anhui Huaheng Biotechnology Co Change In Receivables?

Anhui Huaheng Biotechnology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Anhui Huaheng Biotechnology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Anhui Huaheng Biotechnology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-90 Mil. It means Anhui Huaheng Biotechnology Co's Accounts Receivable increased by ¥90 Mil from Dec. 2022 to Dec. 2023 .

Anhui Huaheng Biotechnology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥258 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Anhui Huaheng Biotechnology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 46.99.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Anhui Huaheng Biotechnology Co's liquidation value for the three months ended in Mar. 2024 was ¥-1,759 Mil.


Anhui Huaheng Biotechnology Co Change In Receivables Historical Data

The historical data trend for Anhui Huaheng Biotechnology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Huaheng Biotechnology Co Change In Receivables Chart

Anhui Huaheng Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.12 -88.39 -138.58 -102.17 -89.70

Anhui Huaheng Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Anhui Huaheng Biotechnology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Huaheng Biotechnology Co  (SHSE:688639) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Anhui Huaheng Biotechnology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=257.909/500.781*91
=46.99

2. In Ben Graham's calculation of liquidation value, Anhui Huaheng Biotechnology Co's accounts receivable are only considered to be worth 75% of book value:

Anhui Huaheng Biotechnology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=370.916-2485.453+0.75 * 257.909+0.5 * 323.962
=-1,759

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Huaheng Biotechnology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Anhui Huaheng Biotechnology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Huaheng Biotechnology Co (SHSE:688639) Business Description

Traded in Other Exchanges
N/A
Address
Shuangfeng Industrial Zone, Anhui Province, Hefei, CHN, 231131
Anhui Huaheng Biotechnology Co Ltd is engaged in the research and development, production and sales of bio-based products such as amino acids and other alanine products.

Anhui Huaheng Biotechnology Co (SHSE:688639) Headlines

No Headlines